HIV/AIDS

Understanding HIV/AIDS

• Overview
• How HIV Causes AIDS
• HIV AIDS Connection
• Transmission
• Symptoms
• Diagnosis
• Treatment
• AZT and AIDS
• Prevention
• Vaccines
• Population Specific Information
• Research Overview
• Publications

Research Areas

• Basic Science
• Epidemiology
• Prevention
• Therapeutics
• HIV Vaccines

Research Highlights

Insights from People Who Keep HIV in Check Naturally

MicroRNAs Help HIV Hide

Early, Consistent Treatment Could Help Eliminate HIV

The NIAID-funded HIV Prevention Trials Network (HPTN) is a collaborative global network of research sites that explores mostly non-vaccine prevention strategies to reduce transmission of HIV.

25 Years of HIV/AIDS Science: Reaching the Poor with Research Advances (Commentary published in Cell)—Nov. 2, 2007

News and Media

IL-2 Immunotherapy Fails to Benefit HIV-Infected Individuals Already Taking Antiretrovirals—Feb. 10, 2009

Q & A: The ESPRIT and SILCAAT HIV Treatment Clinical Studies—Feb. 10, 2009

NIAID Media Availability: New Mathematical Model of Pre-Exposure Prophylaxis (PrEP) Against HIV Forecasts Substantial Benefits, Potential Cost-Effectiveness—Feb. 9, 2009

Anti-HIV Gel Shows Promise in Large-scale Study in Women—Feb. 9, 2009

Q & A: The HPTN 035 Study of Two Candidate Microbicides, BufferGel and PRO 2000 (0.5% dose)
Feb. 9, 2009

National Black HIV/AIDS Awareness and Information Day, February 7, 2009—Feb. 4, 2009

All HIV/AIDS News and Media